Jørgen Johansen

10.2k total citations · 1 hit paper
208 papers, 6.5k citations indexed

About

Jørgen Johansen is a scholar working on Otorhinolaryngology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Jørgen Johansen has authored 208 papers receiving a total of 6.5k indexed citations (citations by other indexed papers that have themselves been cited), including 115 papers in Otorhinolaryngology, 77 papers in Pulmonary and Respiratory Medicine and 47 papers in Oncology. Recurrent topics in Jørgen Johansen's work include Head and Neck Cancer Studies (114 papers), Advanced Radiotherapy Techniques (28 papers) and Lung Cancer Diagnosis and Treatment (26 papers). Jørgen Johansen is often cited by papers focused on Head and Neck Cancer Studies (114 papers), Advanced Radiotherapy Techniques (28 papers) and Lung Cancer Diagnosis and Treatment (26 papers). Jørgen Johansen collaborates with scholars based in Denmark, United States and Norway. Jørgen Johansen's co-authors include Jens Overgaard, Marie Overgaard, Elo Andersen, Cai Grau, Lisbeth Juhler Andersen, Hanne Primdahl, Christian Rønn Hansen, Jesper Grau Eriksen, Carsten Brink and Claus Andrup Kristensen and has published in prestigious journals such as Science, The Lancet and Journal of Clinical Oncology.

In The Last Decade

Jørgen Johansen

190 papers receiving 6.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6&7 randomised controlled trial

2003 481 citations Jens Overgaard, Cai Grau et al. profile →

Peers

Countries citing papers authored by Jørgen Johansen

Since Specialization

Citations

This map shows the geographic impact of Jørgen Johansen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jørgen Johansen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jørgen Johansen more than expected).

Fields of papers citing papers by Jørgen Johansen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jørgen Johansen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jørgen Johansen. The network helps show where Jørgen Johansen may publish in the future.

Co-authorship network of co-authors of Jørgen Johansen

This figure shows the co-authorship network connecting the top 25 collaborators of Jørgen Johansen. A scholar is included among the top collaborators of Jørgen Johansen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jørgen Johansen. Jørgen Johansen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Impact of GTV-CTV margin and other predictors on radiation-induced dysphagia in head and neck cancer patients from DAHANCA group 2025 ·Acta Oncologica ·(unknown), Ruta Zukauskaite, Richard Röttger, Ebbe Laugaard Lorenzen, (unknown), (unknown), (unknown), (unknown), Jørgen Johansen, Jesper Grau Eriksen, (unknown), Jeppe Friborg, Carsten Brink, Christian Rønn Hansen	0
2	DAHANCA19: A randomized phase III study of primary curative (chemo)-radiotherapy and the EGFR-inhibitor zalutumumab for squamous cell carcinoma of the head and neck 2025 ·Radiotherapy and Oncology ·Jesper Grau Eriksen, Christian Maare, Jørgen Johansen, Hanne Primdahl, Åse Bratland, Claus Andrup Kristensen, (unknown), Jan Alsner, Jens Overgaard	2
3	Mutational profile of oropharyngeal squamous cell carcinoma in relation to HPV, tobacco smoking and prognosis with validation in the DAHANCA 19 randomized trial 2025 ·Acta Oncologica ·(unknown), (unknown), P. Lassen, Torben Steiniche, Trine Tramm, Magnus Stougaard, (unknown), Benedicte P. Ulhøi, Jan Alsner, Kasper Toustrup, Christian Maare, Jørgen Johansen, Hanne Primdahl, Claus Andrup Kristensen, Maria Andersen, Jesper Grau Eriksen, Jens Overgaard	0
4	Failure pattern and salvage in head and neck cancer of unknown primary: A national study by DAHANCA 2025 ·Radiotherapy and Oncology ·(unknown), (unknown), Anne I. S. Holm, Ruta Zukauskaite, Christian Rønn Hansen, Christina Caroline Plaschke, Anita Gothelf, (unknown), Eva Samsøe, Martin Skovmos Nielsen, Patrik Sibolt, (unknown), Maria Andersen, Mohammad Farhadi, Hanne Primdahl, Christian Maare, Jørgen Johansen, Christian Godballe, Thomas Kjærgaard, Jens Overgaard	0
5	Radiotherapy quality assurance of patients with squamous cell carcinoma of the head and neck included in the DAHANCA 19 randomised phase III trial 2025 ·Radiotherapy and Oncology ·Christian Rønn Hansen, Eva Samsøe, (unknown), (unknown), A. I. S. Holm, (unknown), Kenneth Jensen, Jørgen Johansen, Christian Maare, Claus Andrup Kristensen, Maria Andersen, Å. Bratland, Cai Grau, Jesper Grau Eriksen, Jens Overgaard	0
6	Patterns of care in de-novo oligo-metastatic and oligo-recurrent head and neck cancers: A Head and Neck Cancer International Group (HNCIG) Survey. 2025 ·Oral Oncology ·Monali Swain, Sarbani Ghosh Laskar, Lachlan McDowell, Christina Henson, Pierluigi Bonomo, Sadhana Kannan, Timothy D. Malouff, Akihiro Homma, Alexander Rühle, Anna Lee, Francesca Caparrotti, James E. Bates, Jørgen Johansen, Juliette Thariat, Marco Ferrari, Miguel Mayo‐Yáñez, Sarah Hamilton, Sue S. Yom, Hisham Mehanna, Petr Szturz	0
7	Epidemiology and treatment outcome of nasopharyngeal carcinoma in a low-incidence population – a DAHANCA analysis in Denmark 2000–2018 2024 ·Acta Oncologica ·(unknown), (unknown), (unknown), Jørgen Johansen, Jesper Grau Eriksen, Christian Maare, (unknown), Mohammad Farhadi, Christian Rønn Hansen, Jens Overgaard, Lisa Lyngsie Hjalgrim, Giedrius Lelkaitis, Jeppe Friborg	1
8	High-dose loco-regional pattern of failure after primary radiotherapy in p16 positive and negative head and neck squamous cell carcinoma – A DAHANCA 19 study 2024 ·Clinical and Translational Radiation Oncology ·(unknown), Anne I. S. Holm, Christian Rønn Hansen, Ruta Zukauskaite, Eva Samsøe, Christian Maare, Jørgen Johansen, Hanne Primdahl, Åse Bratland, Claus Andrup Kristensen, Maria Andersen, Jens Overgaard, Jesper Grau Eriksen	4
9	The effect of hyperbaric oxygen therapy in head and neck cancer patients with radiation induced dysphagia—a systematic review 2024 ·Clinical & Translational Oncology ·(unknown), Malene Korsholm, Max Rohde, Irene Wessel, Lone Forner, Jørgen Johansen, Christian Godballe	1
10	Tumor volume and cancer stem cell expression as prognostic markers for high-dose loco-regional failure in head and neck squamous cell carcinoma – A DAHANCA 19 study 2024 ·Radiotherapy and Oncology ·(unknown), (unknown), Trine Tramm, Jan Alsner, Brita Singers Sørensen, Christian Maare, Jørgen Johansen, Hanne Primdahl, Åse Bratland, Claus Andrup Kristensen, Maria Andersen, (unknown), Anne I. S. Holm, Eva Samsøe, Christian Rønn Hansen, Ruta Zukauskaite, Jens Overgaard, Jesper Grau Eriksen	6
11	A national repository of complete radiotherapy plans: design, Results, and experiences 2023 ·Acta Oncologica ·(unknown), Carsten Brink, Ebbe Laugaard Lorenzen, Eva Samsøe, Ivan R. Vogelius, Ruta Zukauskaite, Birgitte Vrou Offersen, Jesper Grau Eriksen, Olfred Hansen, Jørgen Johansen, (unknown), Christina H. Ruhlmann, Lone Hoffmann, Henrik Dahl Nissen, Martin Skovmos Nielsen, Karen Andersen, Cai Grau, Christian Rønn Hansen	15
12	Evaluation of decentralised model-based selection of head and neck cancer patients for a proton treatment study. DAHANCA 35 2023 ·Radiotherapy and Oncology ·Christian Rønn Hansen, Kenneth Jensen, (unknown), Anne I. S. Holm, Eva Samsøe, Martin Skovmos Nielsen, Patrik Sibolt, P.S. Skyt, U.V. Elstrøm, (unknown), Jørgen Johansen, Ruta Zukauskaite, Jesper Grau Eriksen, (unknown), (unknown), Elo Andersen, Jens Overgaard, Cai Grau, Jeppe Friborg	10
13	HPV testing versus p16 immunohistochemistry in oropharyngeal squamous cell carcinoma: results from the DAHANCA 19 study 2023 ·Acta Oncologica ·(unknown), (unknown), P. Lassen, Torben Steiniche, Trine Tramm, Magnus Stougaard, Christian Maare, Jørgen Johansen, Hanne Primdahl, Claus Andrup Kristensen, (unknown), Jesper Grau Eriksen, Jens Overgaard	7
14	The Danish Head and Neck Cancer Group (DAHANCA) 2020 radiotherapy guidelines 2020 ·Radiotherapy and Oncology ·Kenneth Jensen, Jeppe Friborg, Christian Rønn Hansen, Eva Samsøe, Jørgen Johansen, Maria Andersen, (unknown), Elo Andersen, Martin Skovmos Nielsen, Jesper Grau Eriksen, (unknown), U.V. Elstrøm, Anne I. S. Holm, (unknown), (unknown), P.S. Skyt, Jens Overgaard, Cai Grau	71
15	Comparing the patients’ subjective experiences of acute side effects during radiotherapy for head and neck cancer with four different patient-reported outcomes questionnaires 2019 ·Acta Oncologica ·(unknown), Jørgen Johansen, Christoffer Johansen, Ivan R. Vogelius, Claus Andrup Kristensen, Helle Pappot	17
16	Awareness and surveillance of radiation treatment schedules reduces head and neck overall treatment time 2019 ·Technical Innovations & Patient Support in Radiation Oncology ·Rasmus Lübeck Christiansen, (unknown), (unknown), Morten Nielsen, (unknown), A. Bertelsen, Ruta Zukauskaite, Jørgen Johansen, Christian Rønn Hansen	2
17	Does age affect prognosis in salivary gland carcinoma patients? A national Danish study 2016 ·Acta Oncologica ·Kristine Bjørndal, Stine Rosenkilde Larsen, Marianne Hamilton Therkildsen, Claus Andrup Kristensen, Birgitte Charabi, Elo Andersen, Jens Overgaard, Sten Schytte, H. B. Pedersen, Lisbeth Juhler Andersen, Jørgen Johansen, Christian Godballe	11
18	Affiliation to the work market after curative treatment of head-and-neck cancer: A population-based study from the DAHANCA database 2013 ·Acta Oncologica ·Trille Kristina Kjær, Charlotte Rotbøl Bøje, Maja Halgren Olsen, Jens Overgaard, Jørgen Johansen, Else Helene Ibfelt, Marianne Steding‐Jessen, Christoffer Johansen, Susanne Oksbjerg Dalton	20
19	M-Ficolin, an activator of the complement system is the strongest predictor of both DAS28 remission and low disease activity in a cohort of 180 early DMARD naïve rheumatoid arthritis patients followed in The OPERA-study. 2012 ·University of Southern Denmark Research Portal (University of Southern Denmark) ·Christian Gytz Ammitzbøll, Jens Christian Jensenius, Torkell Ellingsen, Steffen Thiel, Kim Hørslev‐Petersen, Merete Lund Hetland, Peter Junker, Jørgen Johansen, M. Østergaard, Jan Pødenphant, Kristian Stengaard‐Pedersen	1
20	Ectopic histone H3S10 phosphorylation causes chromatin structure remodeling in Drosophila 2008 ·Iowa State University Digital Repository (Iowa State University) ·Huai Deng, Xiaomin Bao, Weili Cai, Melissa J. Blacketer, Andrew S. Belmont, Jack Girton, Jørgen Johansen, Kristen M. Johansen	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact